Holderness Investments CO Amgen Inc Transaction History

Holderness Investments CO

$408 Million
Q1 2024

A detailed history of Holderness Investments CO transactions in Amgen Inc stock. As of the latest transaction made, Holderness Investments CO holds 5,585 shares of AMGN stock, worth $1.73 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

5,585

Previous 5,409 3.25%

Holding current value

$1.73 Million

Previous $1.56 Million 1.93%

% of portfolio

0.39%

Previous 0.43%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $47,321 - $57,122	176 Added 3.25%	5,585 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $5,625 - $6,346	22 Added 0.41%	5,409 $1.56 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $9,620 - $11,944	44 Added 0.82%	5,387 $1.45 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $34,711 - $41,045	162 Added 3.13%	5,343 $1.19 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $60,060 - $73,203	266 Added 5.41%	5,181 $1.25 Million

Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2,290 - $2,910	-10 Reduced 0.2%	4,915 $1.29 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $53,294 - $59,306	-231 Reduced 4.48%	4,925 $1.2 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $62,491 - $69,132	285 Added 5.85%	5,156 $1.25 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $58,072 - $66,459	292 Added 6.38%	4,871 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $14,858 - $17,409	70 Added 1.55%	4,579 $974,000
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $70,541 - $78,260	302 Added 7.18%	4,509 $1.1 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $36,393 - $42,410	164 Added 4.06%	4,207 $1.05 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $237,152 - $282,406	-1,096 Reduced 21.33%	4,043 $930,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $8,682 - $9,655	37 Added 0.73%	5,139 $1.31 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $4,351 - $5,340	-22 Reduced 0.43%	5,102 $1.2 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 7.24%	5,124 $1.04 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $1,892 - $2,432	-10 Reduced 0.18%	5,524 $1.33 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $29,598 - $35,465	-170 Reduced 2.98%	5,534 $1.07 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $8,335 - $9,770	50 Added 0.88%	5,704 $1.05 Million
Q1 2019 May 20, 2019	SELL	$180.87 - $203.88 $1,808 - $2,038	-10 Reduced 0.18%	5,654 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $8,028 - $9,371	45 Added 0.8%	5,664 $1.1 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $6,485 - $7,311	35 Added 0.63%	5,619 $1.17 Million
Q2 2018 Aug 16, 2018	SELL	$166.05 - $186.51 $75,884 - $85,235	-457 Reduced 7.56%	5,584 $1.03 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $21,348 - $24,948	126 Added 2.13%	6,041 $1.03 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $23,799 - $26,591	141 Added 2.44%	5,915 $1.03 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $965,932 - $1.1 Million	5,774	5,774 $1.08 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.

Account

Holderness Investments CO Amgen Inc Transaction History